L&C Bio’s Human-Fat Injection Could Fix “Ozempic Face”: Will Gains Hold?
L&C Bio stock jumps 12% on plans for an Ozempic fix made from donated human fat, backed by patents in three markets.
Opent in een nieuw tabblad. Via Cryptopage meten we de klik voor statistieken.
Partner